
September 2026 Quarterly: First U.S. ROXUS® Prescriptions Fulfilled
LTR Pharma Limited (ASX:LTP) has released its Quarterly Activities Report and Appendix 4C for the three months ending on 30 September 2026. The Quarter saw both U.S. commercial term sheets for ROXUS® converted into definitive agreements, followed shortly after the quarter ended by the first ROXUS prescriptions fulfilled in the

